RxDoctor Payments Data

Christopher Purcell, MD

Family Medicine · Tampa, FLNPI 1184651838

Payments from drug & device makers

$2,467in general payments, 2019–2025

Across 124 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$544
  • Amgen$227
  • Lilly USA, LLC$194
  • Novo Nordisk$182
  • Abbott$178
  • AbbVie$175
  • plus $967 from 17 others

What the payments were for

  • Food & beverage$2,467100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,467 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$107,079
Medicare patients
285
Services billed
1,026

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide160$151,990
JardianceEmpagliflozin65$59,220
XareltoRivaroxaban17$22,909
ProliaDenosumab13$22,019
EliquisApixaban13$20,183
MounjaroTirzepatide13$15,349
Rosuvastatin Calcium433$4,630
Losartan Potassium371$2,804
SynthroidLevothyroxine Sodium28$2,478
Levothyroxine Sodium240$2,466
SymbicortBudesonide/Formoterol Fumarate12$2,416
Atorvastatin Calcium273$2,273
Amlodipine Besylate372$2,247
Metoprolol Succinate102$1,490
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide12$1,245

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$182$151,990160 claims
Boehringer IngelheimJardiance$121$59,22065 claims
Johnson & JohnsonXarelto$13$22,90917 claims
AmgenProlia$227$22,01913 claims
PfizerEliquis$57$20,18313 claims
Lilly USA, LLCMounjaro$194$15,34913 claims
AbbVieSynthroid$175$2,47828 claims
AstraZenecaSymbicort$544$2,41612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →